Significant Ownership of Aberdeen Group plc

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Aberdeen Group plc focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
J. Clarke - Jenny Clarke / Major Shareholding Reporting Analyst
Manager location
Edinburgh, United Kingdom

Significant Ownership of Aberdeen Group plc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ELOX Eloxx Pharmaceuticals Inc Common Stock, $0.01 par value per share 9.9% 400,000 Aberdeen Group plc 30 Jun 2026
CDXS CODEXIS, INC. Common Stock, par value $0.0001 per share 9.9% $15,008,806 +$5,598,570 10,797,702 +59% Aberdeen Group plc 30 Sep 2026
DTIL PRECISION BIOSCIENCES INC Common Stock, par value $0.000005 per share 8.9% $8,896,588 2,138,603 Aberdeen Group plc 31 Dec 2025
IMUX IMMUNIC, INC. Common Stock, par value $0.0001 8% $7,513,042 +$1,832,974 1,090,427 +32% Aberdeen Group plc 30 Sep 2026
NSPR InspireMD, Inc. Common Stock, $0.0001 par value per share 7.5% $5,648,588 +$1,232,200 3,173,364 +28% Aberdeen Group plc 31 Dec 2025
SERA SERA PROGNOSTICS, INC. Class A Common Stock $0.0001 par value per share 7.2% $5,507,050 +$1,052,316 2,753,525 +24% Aberdeen Group plc 30 Jun 2026
EQ Equillium, Inc. Common Stock, $0.0001 Par Value 7% $6,330,858 +$1,569,830 4,458,351 +33% Aberdeen Group plc 30 Sep 2026
IMUX IMMUNIC, INC. Common Stock, par value $0.0001 per share 6.8% $4,399,791 8,243,941 0% Aberdeen Group plc 31 Dec 2025
PRQR ProQR Therapeutics NV Ordinary Shares, nominal value EUR0.04 per share 6.3% $16,614,463 8,932,507 Aberdeen Group plc 30 Jun 2026
QURE uniQure N.V. Ordinary Shares, par value(euro)0.05 per share 4.5% $131,184,269 -$113,227,870 2,848,117 -46% Aberdeen Group plc 30 Jun 2026
QNRX Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing Thirty-five (35) Ordinary Shares, no par value per share 4.2% $491,250 75,000 0% Aberdeen Group plc 01 Apr 2026
TECX Tectonic Therapeutic, Inc. Common Stock, $0.0001 par value per share 2.5% $11,293,552 -$15,300,785 484,887 -58% Aberdeen Group plc 30 Sep 2026
PCSC Freenome, Inc. Common Stock, par value $0.0001 per share 0.61% $7,781,611 +$925,615 656,676 +14% Aberdeen Group plc 30 Sep 2026
CRBP Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share 0% $0 -$9,014,599 0 -100% Aberdeen Group plc 16 Sep 2026

Schedules 13D/G Reported by Aberdeen Group plc:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .